MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition

Christina M. Knippler(The Ohio State University Wexner Medical Center), Matthew D. Ringel(The Ohio State University Wexner Medical Center)
Endocrine Related Cancer
May 30, 2019
Cited by 26


Related Papers